Silo Pharma rises on filing of patent for Alzheimer's treatment

Silo Pharma

13/02/2023 19:15

** Shares of drug developer Silo Pharma Inc  SILO.O  jump
13% to $2.8
    ** Co files for patent for the use of its central nervous
system homing peptides to treat Alzheimer's disease and the
onset of dementia
    ** Homing peptides are amino-acid compounds that bind at
specific sites in the body and can be used as targeted delivery
vehicles for drugs
    ** Patent application covers use of novel homing peptides to
reduce toxicity and delivering drug payload
    ** Stock down 71% in last 12 months
 (Reporting by Aditya Samal)
 ((Aditya.Samal@thomsonreuters.com;))